Literature DB >> 30468480

miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.

X-H Wei1, X-L Gu, X-T Zhou, M Ma, C-X Lou.   

Abstract

OBJECTIVE: To explore the possible role and mechanism of miR-497 in cutaneous squamous cell carcinoma. PATIENTS AND METHODS: Quantitative Real-time polymerase chain reaction (qRT-PCR) was used to detect miR-497 and FAM114A2 expression level in 38 cases of cutaneous squamous cell carcinoma (CSCC) and 22 normal skin tissues as well as in CSCC cell lines (A431, HSC-5) and normal cells (HaCaT). MiR-497 effects on cell proliferation and cell cycle were examined by CCK8 assays and flow cytometry. Dual luciferase reporter gene assay was performed to detect the regulating relationship between miR-497 and FAM114A2. In addition, the expression of FAM114A2 after overexpression or knockdown of miR-497 was detected by Western blot to evaluate whether miR-497 could regulate proliferation and cell cycle by regulating the expression of FAM114A2.
RESULTS: MiR-497mRNA expression in CSCC tissues and cell lines was markedly lower than that in normal tissues and cells. Meanwhile, FAM114A2 mRNA and protein levels in CSCC tissues were markedly higher when compared to than that in normal tissues. miR-497 overexpression or knockdown could inhibit or promote the cell proliferation and cell cycle of A431, HSC-5. The dual luciferase reporter gene assay suggested that FAM114A2 might be a direct target gene of miR-497, and that FAM114A2 expression had a significant negative correlation with miR-497. Overexpression of miR-497 could inhibit FAM114A2 protein expression. Besides, FAM114A2 knockdown reversed the inhibitory effect of low expression of miR-497 on proliferation rate of A431 or HSC-5 cells.
CONCLUSIONS: MiR-497 was lowly expressed in squamous cell carcinoma tissues and cells, which can participate in the regulation of cell proliferation through FAM114A2, thus promoting the progression of CSCC.

Entities:  

Year:  2018        PMID: 30468480     DOI: 10.26355/eurrev_201811_16272

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  RNA-Seq Profiling of Circular RNAs and the Oncogenic Role of circPVT1 in Cutaneous Squamous Cell Carcinoma.

Authors:  Shuang Chen; Junli Ding; Yunlin Wang; Tao Lu; Lili Wang; Xinghua Gao; Hongduo Chen; Le Qu; Chundi He
Journal:  Onco Targets Ther       Date:  2020-07-12       Impact factor: 4.147

2.  CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.

Authors:  Xiaoqing Li; Yinghui Kong; He Li; Manyuan Xu; Ming Jiang; Weiguo Sun; Suping Xu
Journal:  Genes Genomics       Date:  2021-03-11       Impact factor: 1.839

3.  Knockdown of long non‑coding RNA DDX11‑AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA‑497 expression.

Authors:  Meng Liang; Beibei Zhu; Min Wang; Ju Jin
Journal:  Mol Med Rep       Date:  2022-02-16       Impact factor: 2.952

Review 4.  Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.

Authors:  Stephenie Droll; Xiaomin Bao
Journal:  Cell Physiol Biochem       Date:  2021-09-22

5.  MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma.

Authors:  Yanhua Wang; Shengjian Tang; Jianping Lv
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.759

Review 6.  Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.

Authors:  Fei Liu; Shenglong Li
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

7.  MicroRNA miR-497 is closely associated with poor prognosis in patients with cerebral ischemic stroke.

Authors:  Changyang Zhong; Congguo Yin; Guozhong Niu; Li Ning; Jinbo Pan
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.